Adjuvant rather than antigen choice will accelerate the development of malaria vaccines.
SourceParasite Immunology, 28, 2, (2006), pp. 253-254
Article / Letter to editor
Display more detailsDisplay less details
SubjectN4i 3: Poverty-related infectious diseases; N4i 4: Auto-immunity, transplantation and immunotherapy; NCMLS 1: Immunity, infection and tissue repair; NCMLS 1: Infection and autoimmunity; UMCN 4.1: Microbial pathogenesis and host defense
Upload full text